INO5042 is primarily investigated for its potential therapeutic applications in treating various medical conditions. It is being studied for its role in targeting specific pathways involved in inflammation and autoimmune disorders. Researchers are exploring its efficacy in modulating immune responses, which could make it a promising candidate for managing diseases like rheumatoid arthritis, lupus, and other chronic inflammatory conditions. Additionally, its potential neuroprotective properties are being examined for applications in neurodegenerative diseases such as Alzheimer's and Parkinson's. Preclinical studies suggest that INO5042 may help in reducing neuronal damage and improving cognitive functions. Further research is ongoing to determine its safety, efficacy, and potential use in clinical settings.